The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Sarcopenia vs body mass index (BMI) as a prognostic biomarker in patients with metastatic clear cell renal cell carcinoma (mCCRCC) in the era of first line immune checkpoint inhibitors (ICIs).
 
Bryce Douglas La Course
No Relationships to Disclose
 
Delaney Orcutt
No Relationships to Disclose
 
Evan Gross
No Relationships to Disclose
 
Florian J. Fintelmann
Consulting or Advisory Role - Jounce Therapeutics; Pfizer (Inst)
Research Funding - BTG (Inst)
Patents, Royalties, Other Intellectual Property - Patent related to body composition analysis on CT scans; Royalties from writing a book with Elsevier (publisher)
 
Viraj A. Master
Honoraria - Ethicon; Exelixis
 
Evan Thomas Hall
Research Funding - ImCheck therapeutics (Inst); Nektar (Inst); Neoleukin Therapeutics (Inst); NiKang Therapeutics (Inst); Replimune (Inst); Treatment Technologies and Insights (Inst)
 
Maria Marta Wrobel
No Relationships to Disclose
 
Sarah P. Psutka
Honoraria - AstraZeneca
Consulting or Advisory Role - Janssen; Merck
Travel, Accommodations, Expenses - medtronic